Development of Online Courses Clause Samples

Development of Online Courses. Faculty members who develop full online courses in the model of the Online College Project per 32.02.H.2 may claim up to 14 hours of compensation at the base hourly rate per course unit.
Development of Online Courses. The compensation for development of online courses shall be: A. $1,500 for first course (subject) converted to wholly online. B. $1,000 for second course (subject) converted to wholly online. C. $500 for every subsequent course (subject) converted to wholly online. Salary Rates for Ancillary and Other Duties 2017-18 (002) Table of Contents - ▇▇▇▇▇▇▇▇ Creek Correctional Center
Development of Online Courses. The first time a course is developed as an online or hybrid course, the Association Member will be given a supplemental contract equal to the course contact hours in the development semester. If developing a new online or hybrid course, the Association Member, in consensus with the Department/Program chair, will have first choice as to whether they want to develop the course. Completely redesigning a previously designed but unsuccessful course can be submitted to the supervising ▇▇▇▇ as a request for a special assignment. Blended course design can be submitted to the supervising ▇▇▇▇ as a request for a special assignment.
Development of Online Courses. The compensation for development of online courses shall be: A. $1,500 for first course (subject) converted to wholly online. B. $1,000 for second course (subject) converted to wholly online. C. $500 for every subsequent course (subject) converted to wholly online. Table of Contents ARTICLE I: RECOGNITION 3 ARTICLE II: MANAGEMENT RIGHTS / RESPONSIBILITIES 3 ARTICLE III: WORKING CONDITIONS 3 ARTICLE IV: WORKLOAD AND TERMS OF EMPLOYMENT 4 ARTICLE V: LEAVE POLICY 5 ARTICLE VII: HIRING OF FACULTY 7 ARTICLE VIII: REVIEW OF FACULTY 7 ARTICLE IX: DISMISSAL 7 ARTICLE X: FACULTY DISABILITY SEPARATION PROCEDURE 8 ARTICLE XI: REDUCTION IN FORCE 8 ARTICLE XII: SALARY SCHEDULE PLACEMENT AND MOVEMENT 9 ARTICLE XIII: GRIEVANCE 9 ARTICLE XIV: BENEFITS 9 ARTICLE XV: EXCEPTIONAL FACULTY AWARDS 9 ARTICLE XVI: SAVINGS CLAUSE 10 ARTICLE XVII: SCOPE OF AGREEMENT 10 ARTICLE XVIII: UNINTERRUPTED INSTRUCTIONAL ACTIVITIES 10 ARTICLE XIX: DURATION OF THE CONTRACT 10

Related to Development of Online Courses

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development Diligence Pfizer will use its Commercially Reasonable Efforts to Develop and seek Regulatory Approval for one Product in the Field in [***]. Pfizer will have no other diligence obligations with respect to the Development or Regulatory Approval of Products under this Agreement.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).